To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

  • Home
  • Technologies of MAX Contact Lenses Address a Lifetime of Needs
    Print Button

    Home

    Technologies of MAX Contact Lenses Address a Lifetime of Needs

    Published on Feb 10, 2021
    15 Minutes Read

    Meredith Bishop, OD, MS, FAAO; David Ruston, BSc, FCOptom, DipCLP, FAAO; and John Buch, OD, MS, FAAO

    With adults spending more time on screens combined with the fact that half of patients over age 45 will drop out of contact lens wear,‡ it is imperative that the technologies built into your contact lenses address these factors related to the aging population. ACUVUE® OASYS MAX 1-Day MULTIFOCAL includes three unique technologies that do just that.

    In this age of digital technology, lifestyles demand more from our vision. A persistent trend toward longer screen times – and the burden this can put on eyes – is well documented. Over the last few years, the average time adults spend using screens has increased by 33% to about 13.5 hours per day.1 A recent change that may have contributed to this trend is the shift to remote working and the associated increase in video teleconferencing.

    The number and variety of digital devices people use is also on the rise; nowadays, a typical household owns around 25 connected devices.2 The burden this puts on the eye can include symptoms of both ocular and visual discomfort. The direct causes of these symptoms include altered blinking and accompanying tear film issues at all ages,3-5 accommodative and convergence demands,6 and glare.7

    These demands can be even more troubling for the aging eye. Accommodation declines, impacting near vision. Tear film break up time reduces 50% by age 50,8 which can lead to dryness and inconsistent vision, and light scatter doubles by age 60, resulting in increased visual artifacts.9

    Given these increasing visual challenges, contact lens designs must provide further technological advancements to meet patients’ needs. End-of-day comfort is a key consideration among eye care practitioners, with 74% viewing it as the number one performance gap.10 Another important challenge is vision under various light conditions, for example, many patients have difficulties with the visual requirements of driving at night.11  Lastly, patients report that near vision provided by multifocal contact lenses could also be improved.12

    Technologies for Comfort Clarity

    ACUVUE® MAX Multifocal is designed to help address contact lens needs of the presbyopic patient, combining three powerful technologies: Pupil Optimized Design, TearStableTM Technology, and the OptiBlueTM Light Filter. Most of your presbyopic patients can benefit from these innovative technologies, which make ACUVUE® MAX Multifocal a great choice for upgrading existing contact lens wearers and first-time wearers.

    Technology Number One: Pupil Optimized Design

    Of contact lens wearers older than 40, 94% expect to continue in contact lenses.§13 Despite this, half of patients over age 45 will drop out of contact lens wear.‡

    Pupil size varies with age and refraction: older and more hyperopic eyes tend to have smaller pupils.15,16 By tailoring optical parameters to pupil-size variation across both near and distance powers, ACUVUE® MAX Multifocal is designed for superior visual performance.†14  The Pupil Optimized Design also enables a high rate of fitting success, with 96% of patients successfully fit using two pairs of lenses or fewer.*17

     

    Technology Number Two: TearStableTM

    TearStableTM Technology supports a stable tear film by mimicking the moisturizing and lubricating properties of the tear film.18–21 To do this, ACUVUE® MAX Multifocal optimizes the distribution of the wetting agent (PVP) throughout the lens and at the surface.18-21 The wetting agent allows both water and lipid components of the tear film to spread over a surface, enabling moisture retention and lubrication.22-24 This is designed to lock moisture throughout the lens and across the surface.18

    Objective measures indicate that the benefits provided by TearStableTM Technology include  reduced tear evaporation**18,19 and enhanced tear-film stability.§§20 With the ACUVUE® MAX family of contact lenses, tear evaporation is almost halved when compared to competitors’ lenses.††18,19 As for tear film stability, wearers of ACUVUE® MAX  are 1.6 times more likely to have an increased tear film break-up time (VBUT).§§20 Compared to a leading contact lens, ACUVUE® MAX increased the proportion of patients with a VBUT >10 seconds, reflecting an improved tear film stability and optical quality.§§20

    Technology Number Three: OptiBlueTM Filter#

    High-energy, blue-violet light (380–450 nm) can be emitted from various sources, such as indoor lighting, car headlights, and digital devices, as well as the sun.

    Longer blue wavelengths of around 460 nm to 500 nm are responsible for regulating pupillary light reflexes and circadian rhythm,25 with exposure to these wavelengths leading to reduced sleepiness,26 increased alertness,27 and increased cognitive function.28 Therefore, while the macular pigment provides some filtering at these longer wavelengths, additional filtering could reduce or delay the associated biological processes.29

    The shorter blue-violet light can have a negative effect on visual comfort and clarity; these wavelengths are more uncomfortable to view than the longer orange/red wavelengths (assuming equal luminous output).30,31 They are also scattered more easily within the eye than longer wavelengths, thus reducing retinal contrast.32 Therefore, filtering at these shorter wavelengths of the blue-violet range can improve both subjective and objective visual outcomes.30,31,33

    Not all blue-violet light filters are created equal – they can have different levels of filtering and act on different regions of the light spectrum. The OptiBlueTM Filter provides the highest level of blue-violet light filtering, reducing blue-violet light transmission by 60% within a range of shorter wavelengths (Figure 1).#‡‡18 ACUVUE® MAX Multifocal is designed to reduce intraocular light scatter, starbursts, halos and thereby improve visual clarity.#18,34

    Figure 1. Spectral transmittance curves for ACUVUE® OASYS 1-DAY (blue) and ACUVUE® OASYS MAX 1-DAY (yellow) across a range of wavelengths, including ultraviolet (UV) high-energy visible (HEV) and visible light. #,^,^^,19

    Clinical Performance of ACUVUE® MAX Multifocal

    ACUVUE® MAX Multifocal provides crisp, clear vision at all distances and in all lighting conditions plus all-day comfort.17 When compared to Dailies Total1® Multifocal, ACUVUE® MAX Multifocal offers superior near and intermediate vision with comparable distance vision.¶35 Additionally, after wearing ACUVUE®  MAX Multifocal, 94% of patients reported comfort throughout the day and 90% reported end-of-day comfort.17

    ACUVUE® MAX Multifocal offers clarity in all lighting conditions.17 Compared to Dailies Total1® Multifocal, ACUVUE® MAX Multifocal provides superior vision during daily activities, and superior vision in dim light.¶35 In addition, the majority of ACUVUE® MAX Multifocal wearers reported feeling confident driving at night.¶¶

    In clinical trials, the lens also shows benefits for viewing digital devices. 94% of patients wearing ACUVUE® MAX Multifocal reported clear vision using digital devices.17 The wearers of ACUVUE® MAX Multifocal also experienced less feelings of tired eyes using digital devices.¶35

    Conclusion

    Many patients are struggling to keep up with today’s visually demanding lifestyles. ACUVUE® MAX Multifocal uses three innovative technologies – Pupil Optimized Design, TearStableTM Technology, and the OptiBlueTM filter – to meet more presbyopic needs.^‖  Now is the time to offer the multifocal contact lens your patients have been waiting for.

    ‡ JJV Data on File 2021. Growth Levers analysis based on IPSOS Global /Appinio Incidence Tracker, retail outlet consumption data and national census population data covering the United States, United Kingdom, Russia, Japan, South Korea, and China.
    # Filtering of high-energy visible light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle.  An eye care professional should be consulted for more information.
    § Intention to continue wearing contact lenses based on indicating: definitely/probably would continue wearing contact lenses in the next 12 months.      
    † Compared to prior JJVC multifocal design, technology optimized for both the parameters of refractive error and add power for a multitude of viewing distances and light levels.
    * four lenses in total.
    ** Versus ACUVUE® OASYS 1-Day, Dailies Total1®, My Day® and Infuse®, and Precision1®
    §§ More wearers achieved a visual tear break up time ≥ 10 seconds compared to ACUVUE® OASYS 1-Day.
    †† Versus Dailies Total1®, My Day® and Infuse®, also significantly lower versus ACUVUE® OASYS 1-Day.
    ‡‡Versus publicly available information for standard daily use contact lenses as of July 2022.
    ^‖ versus 1-DAY ACUVUE® MOIST MULTIFOCAL and ACUVUE® OASYS MULTIFOCAL
    ¶Versus Dailies Total1® Multifocal
    ¶¶JJV Data from the ACUVUE® OASYS MAX 1-Day In-Practice Assessment, with 81 participating Optometrists and 605 spherical and 390 multifocal patients in the US from July to October 2022.

    ^Helps protect against transmission of harmful UV radiation to the cornea & into the eye.
    ^^WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area.  You should continue to use UV-absorbing eyewear as directed.  NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts.  Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities).  UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

     
    Dr. Meredith Bishop is Senior Manager Global Professional Education and Development; Dr. John Buch is Senior Principal Research Optometrist at Johnson & Johnson Vision Care, Inc.; and David Ruston is Director Global Professional Education and Development at Johnson & Johnson Medical Ltd.

    1. Eyesafe estimate based upon Nielsen Q3 2019 Total Audience Report. https://eyesafe.com/covid-19-screen-time-spike-to-over-13-hours-per-day/

    2. Brassfield M. IT Pro. 9 Jun 2021. https://www.itpro.co.uk/mobile/mobile-phones/359826/smart-devices-more-t...

    3. Portello JK, Rosenfield M, Chu CA. Blink rate, incomplete blinks and computer vision syndrome. Optom Vis Sci 2013; 90: 482–7.

    4. Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328(8):584.

    5. Patel S, Henderson R, Bradley L, et al. Effect of visual display unit use on blink rate and tear stability. Optom Vis Sci 1991;68(11):888–92.

    6. Watten RG, Lie I, Birketvedt O. The influence of longterm visual near-work on accommodation and vergence: a field study. J Hum Ergol (Tokyo) 1994;23:27–39.

    7. Thorud H, Helland M, Aarås A, et al. Eye-related pain induced by visually demanding computer work. Optom Vis Sci 2012; 89: E452–64.

    8. Mostafa Y, SaifM, Saeed M, and ElSaadanyS. The Effect of Age and Gender on Tear Film Breakup Time. Egyptian Journal of Medical Research. 2021;2:137-148.

    9. Van Den Berg TJ, Van Rijn LJ, Michael R, et al. Straylight effects with aging and lens extraction. Am J Ophthalmol2007;144(3):358-363.

    10. ACUVUE® OASYS MAX 1-Day Market Research Dec 2019 n=300 US ECPs. 

    11. National Highway Traffic Safety Administration (NHTSA), Varghese C, Shankar U. Traffic Safety Facts: Research Note. Passenger Vehicle Occupant Fatalities by Day and Night—A Contrast; DOT HS 810 637. Washington, DC: National Center for Statistics and Analysis, NHTSA; 2007.

    12. Bennett ES. Contact lens correction of presbyopia. Clinical and experimental optometry. 2008;91:265–78.

    13. JJV Data on File 2021. Survey conducted with n= 1,750 representative U.S. and U.K. consumers, ages 12–64.

    14. JJV Data on File 2022. ACUVUE® PUPIL OPTIMIZED DESIGN TECHNOLOGY. JJV Contact Lenses, Design Features, and Associated Benefits.

    15. Birren JE, Casperson RC, Botwinick J. Age changes in pupil size. Journal of Gerontology. 1950 Jul 1;5(3):216–21.

    16. Cakmak HB, Cagil N, Simavlı H, et al. Refractive error may influence mesopic pupil size. Current eye research. 2010 Feb 1;35(2):130–6.

    17. JJV Data on File, Subjective Stand-Alone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses – Exploratory Meta-analysis.

    18. JJV Data on File 2022. TearStableTM Technology Definition.

    19. JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable™ Technology Brand Contact Lenses and other daily disposable contact lens brands.

    20. JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts of ACUVUE® OASYS MAX 1-Day Family with TearStable™ Technology.

    21. Ruben MaG, M. Contact Lens Practice. London: Chapman & Hall. 1984.

    22. Sterner O, Karageorgaki C, Zürcher M, et al. Reducing Friction in the Eye: A Comparative Study of Lubrication by Surface-Anchored Synthetic and Natural Ocular Mucin Analogues. ACS Applied Materials & Interfaces. 2017/06/14 2017;9(23):20150–60.

    23. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).

    24. Marten L. N-Vinyl Amide Polymers. In: Mark HF, ed. Encyclopedia of Polymer Science and Engineering. Hoboken, NJ: John Wiley & Sons/Interscience, 1989:198–257.

    25. Panda S, Nayak SK, Campo B, et al. Illumination of the melanopsin signaling pathway. Science. 2005 Jan 28;307(5709):600–4. 

    26. Motamedzadeh M, Golmohammadi R, Kazemi R, et al. The effect of blue-enriched white light on cognitive performances and sleepiness of night-shift workers: A field study. Physiol Behav. 2017 Aug 1;177:208–14.

    27. Lockley SW, Gooley JJ. Circadian photoreception: spotlight on the brain. Current Biology. 2006 Sep 19;16(18):R795–7.

    28. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002 Feb 8;295(5557):1070–3. 

    29. Arunkumar R, Calvo CM, Conrady CD, et al. What do we know about the macular pigment in AMD: the past, the present, and the future. Eye. 2018 May;32(5):992–1004.

    30. Flannagan MJ, Sivak M, Ensing M, et al. Effect of wavelength on discomfort glare from monochromatic sources. University of Michigan, Ann Arbor, Transportation Research Institute; 1989.

    31. Stringham JM, Fuld K, Wenzel AJ. Action spectrum for photophobia. JOSA A. 2003 Oct 1;20(10):1852–8. 

    32. Aslam TM, Haider D, Murray IJ. Principles of disability glare measurement: an ophthalmological perspective. Acta Ophthalmol Scand. 2007;85:354–60.

    33. Hammond BR, Fletcher LM, Roos F, et al. A Double-Blind, Placebo-Controlled Study on the Effects of Lutein and Zeaxanthin on Photostress Recovery, Glare Disability, and Chromatic Contrast. Investigative Ophthalmology & Visual Science. 2014;55(12):8583–9.

    34. JJV Data on File 2022. Blue-Violet Filter Utilized in ACUVUE® OASYS MAX 1-Day contact lenses.

    35. JJV Data on File 2022: ACUVUE OASYS MAX 1-Day MULTIFOCAL vs DAILIES TOTAL1 Multifocal Contact Lenses Comparative and Additional Descriptive Subjective Claims.

    _______________________

    Important safety information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching, or discomfort. Lenses should not be prescribed if patients have any eye infection or experience eye discomfort, excessive tearing, vision changes, redness, or other eye problems. Consult the package insert for complete information. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-800-843-2020, or by visiting www.jnjvisionpro.com.

    Helps protect against transmission of harmful UV radiation to the cornea & into the eye.

    WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities).  UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

    Filtering of high-energy visible light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle. An eye care professional should be consulted for more information.

    All third-party trademarks herein are the intellectual property of their respective owners.

    Johnson & Johnson Vision Care, Inc. 2023

    PP2023MLT5148 v2